YouTuber Hank Green diagnosed with Hodgkin lymphoma - dofaq.co
YouTuber Hank Green diagnosed with Hodgkin lymphoma
CNN - 19 May 2023
YouTuber, science educator and writer Hank Green announced on Friday that he has been diagnosed with Hodgkin lymphoma, a form of blood cancer.
Discovery suggests new strategy against follicular lymphoma
Medical Xpress - 28 Mar 2024
Discovery suggests new strategy against follicular lymphoma ...
B-Cell Lymphoma With Prominent Presentation of Lactic Acidosis: A Case Report and Brief Review of the Literature
Cureus - 29 Mar 2024
B-Cell Lymphoma With Prominent Presentation of Lactic Acidosis: A Case Report and Brief Review of the Literature ...
Genmab to expand in New Jersey in bid to boost Epkinly rollout
FiercePharma - 28 Mar 2024
Genmab to expand in New Jersey in bid to boost Epkinly rollout ...
FDA Issues CRLs for Odronextamab in R/R Follicular Lymphoma and R/R DLBCL
OncLive - 25 Mar 2024
FDA Issues CRLs for Odronextamab in R/R Follicular Lymphoma and R/R DLBCL ...
FDA Rejects Regeneron’s Blood Cancer Therapy for Two Forms of Lymphoma
BioSpace - 25 Mar 2024
FDA Rejects Regeneron’s Blood Cancer Therapy for Two Forms of Lymphoma ...
Texas Children's patient Olivia channels hope, love of golf in HLH, lymphoma battle - PGA TOUR
PGA TOUR - 27 Mar 2024
Texas Children's patient Olivia channels hope, love of golf in HLH, lymphoma battle - PGA TOUR ...
FDA Issues CRLs for Odronextamab in R/R Follicular Lymphoma, R/R DLBCL
AJMC.com Managed Markets Network - 25 Mar 2024
FDA Issues CRLs for Odronextamab in R/R Follicular Lymphoma, R/R DLBCL ...
Regeneron's (REGN) Lymphoma Candidate Rejected by the FDA
Yahoo Finance - 26 Mar 2024
Regeneron's (REGN) Lymphoma Candidate Rejected by the FDA ...
Advances in Lymphoma Research - NCI
National Cancer Institute (.gov) - 27 Feb 2024
Advances in Lymphoma Research - NCI ...
Lymphoma: Symptoms, Causes and Treatment
Cleveland Clinic - 09 Jun 2023
Lymphoma: Symptoms, Causes and Treatment ...
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy
Nature.com - 24 Jan 2024
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy ...
'I feel like myself again': UCLA clinical trial offers hope for lymphoma patients
University of California - 14 Mar 2024
'I feel like myself again': UCLA clinical trial offers hope for lymphoma patients ...
Regeneron's blood cancer therapy faces setback as FDA raises trial concerns
Reuters - 25 Mar 2024
Regeneron's blood cancer therapy faces setback as FDA raises trial concerns ...
A Rare Case of Low-Grade B-cell Non-Hodgkin's Lymphoma of the Lower Lip Mimicking a Mucocele
Cureus - 29 Mar 2024
A Rare Case of Low-Grade B-cell Non-Hodgkin's Lymphoma of the Lower Lip Mimicking a Mucocele ...
The Many Faces of Lymphoma
Bristol Myers Squibb - 02 Nov 2023
The Many Faces of Lymphoma ...
Recent Data on Axi-Cel in Lymphoma
OncLive - 26 Mar 2024
Recent Data on Axi-Cel in Lymphoma ...
Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling
Nature.com - 11 Dec 2023
Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling ...
Observational Study Shows Frontline Ibrutinib With/Without Rituximab Is Safe and Effective in Low-Risk Mantle Cell ...
OncLive - 28 Mar 2024
Observational Study Shows Frontline Ibrutinib With/Without Rituximab Is Safe and Effective in Low-Risk Mantle Cell ... ...
Multifocal Primary Extranodal Non-Hodgkin Lymphoma: A Report of a Rare Case
Cureus - 28 Mar 2024
Multifocal Primary Extranodal Non-Hodgkin Lymphoma: A Report of a Rare Case ...